Mapping The Next Three Decades of Health Technology. When science fiction films depict the future, the best writers and directors are often less concerned with accurately predicting how specific technologies might reshape the world than they are with confronting the moral or philosophical quandaries of present day.
It’s what makes those stories compelling--and relatable. When futurists attempt to tell us how (and when) technology leaps will occur, they’re not only speculating about what we’re capable of achieving in the coming decades but also imploring us to prepare--scientifically and psychologically--for those events. Envisioning Technology, the firm behind the massive infographic explorations of the future of emerging technology and the future of education technology, is, as you might guess, run by a futurist: Michell Zappa. His most recent visualization maps the next three decades of health technology, charting how regeneration, augmentation, diagnostics, treatments, biogerontology, and telemedicine will change over time.
Healthcare - l'e-santé au service du bien vieillir. Le profil démographique du monde change radicalement, le nombre de personnes âgées augmentant face à un nombre de jeunes en constante diminution.
Mobile Site or Mobile App: Which Should You Build First? [INFOGRAPHIC] Astute Internet observers know by now that the future of the web is mobile.
More and more consumers will access data and information via smartphones, tablets and other portable devices. So businesses need to prepare by beefing up their presences on the mobile web. But is it better to get started by creating a mobile-optimized website or by building a standalone mobile app? A mobile app is faster, more interactive and can integrate with all kinds of other phone features. But the app must be installed to be of any use at all, while a good mobile site can simply be navigated to on a user's whim. Mobile apps are becoming more and more popular with Internet users, however.
SEE ALSO: In a Relationship: Mobile Apps and the Cloud [INFOGRAPHIC] Maybe the answer to what to develop first is embedded in what type of service you're looking to provide. The advertising agency MDG pulled data from sources including Flurry Analytics, ComScore and others to create the infographic below. Sante2025_LivreBlanc_BD.pdf (Objet application/pdf) Web 2.0 and Social Media in Medical Education: Slideshow. European_doctors_social_media_infographic_large.pdf (Objet application/pdf) Pharma and facebook: the cost of disengagement. Yesterday, facebook opened comments on all its fan pages and consequently closed a chapter in the book of pharma social media engagement.
As expected, (and brilliantly monitored by Jonathan Richman here ) many companies, like Novartis , immediately shut down their fan pages in reaction to these changes. Other companies though, like Boehringer or JNJ , had enabled comments ages ago already and happily continued engaging on facebook. Still some others, like Pfizer or GSK seemed yet unsure as to how to handle this situation. This made me wonder: How do you make the decision whether to stay on facebook? Will it make a difference to anyone that some pharmacos chose to leave? As always, I had to delve into some stats to make up my mind up about these questions.
Just as on twitter , Pfizer is leading the benchmark with over 31k fans! Internet access drives information access. 59% of all adults in the U.S. look for health information online.
Eight in ten internet users look online for health information, making it the third most popular online activity among all those included in the Pew Internet Project’s surveys. Internet access drives information access. Since one-quarter of adults do not go online, the percentage of health seekers is lower among the total population: 59% of adults in the U.S. look online for health information.
Women, non-Hispanic whites, younger adults, and those with higher levels of education and income are more likely than other demographic groups to gather health information online. There are two forces at play in the data: access to the internet and interest in health information. For the other groups, the rate of internet adoption combined with their level of interest in health information drives their numbers either up or down.
The typical search for health information is on behalf of someone else. PHARMA GEEK / Démographie médicale Instantané 2012 des médecins français Infographie vendredi 23 mars 2012. PHARMA GEEK & SOCIAL MEDIA. “There’s a tension between opportunity and risk”, says Simon Quayle, Director of Digital Communications at GSK, describing his work leading the company’s corporate social media engagement.
And he should know – he was responsible for making GSK’s Facebook page one of the world’s first ‘open’ pharma social media environments, encouraging public stakeholders to post comments during a time when most pharmaceutical companies kept their pages tightly locked down. That was in the days when Facebook allowed pharmaceutical companies to ‘switch off’ commenting from their pages; a practice that has since been banned by Facebook, forcing less-prepared companies to either close down their Facebook pages or rapidly adapt to two-way public engagement. GSK featured in my “Top 10” pharma social media firsts of 2013 for exceeding 90,000 Facebook ‘Likes’; today, Likes on the company’s page are rapidly approaching 100,000. 1. Learn what engages people 2. GSK uses other dedicated channels, too. 3. 4. 5. KRESMOI_internet_health_search_information_HON.pdf (Objet application/pdf)
Un rapport à lire sur les enjeux entourant le développement des réseaux sociaux en santé. Le Conseil général de l’industrie, de l’énergie et des technologies français a publié en mai 2011 un rapport particulièrement intéressant sur les enjeux entourant le développement des réseaux sociaux dans le domaine de la santé.
Selon les auteurs, les transformations qu’amène le «web social» seraient précurseurs «d’un nouveau rapport de notre société avec la question sanitaire et sociale» (Picard, 2011, p.11). Barometre_TIC_2011.pdf (Objet application/pdf) Ehealth_benchmarking_3_final_report.pdf (Objet application/pdf)